Solae was the first company to develop and introduce soy protein isolate for the infant formula application more than 40 years ago. Today, about one in four formula-fed infants in the United States are fed a tolerance-based formula such as soy‑based infant formula. soy‑based infant formulas are generally recommended for infants experiencing intolerance to milk-based formulas, which can cause temporary or ongoing digestive issues in infants.
In such formulas, soy protein provides a safe
, high-quality, complete source of protein nutrition, critical to supporting healthy growth and development. Solae's specialized products for the infant formula market are developed to precisely meet the strict quality and safety standards so critical to this segment. Solae's soy proteins for infant formulas have been tested in numerous clinical trials. These trials support soy's ability to effectively meet protein needs in infants. As the pioneers of this market, and with 40-plus years experience with infant formula, Solae's research and development team of food and nutrition scientists has a wealth of experience in the application and knowledge of the unique needs of this market.